{"SPADE_N_06909": {"Clinical Information": [], "Patent Information": [{"Patent No": "US20140140929A1", "Patent Link": "http://www.lens.org/lens/patent/US20140140929A1", "Patent Type": "Granted Patent", "Publication Date": "2014-5-22", "Family Info": "Notavailable", "Patent Title": "CHEMICALLY MODIFIED CELL-PENETRATING PEPTIDES FOR IMPROVED DELIVERY OF GENE MODULATING COMPOUNDS", "Abstract": "The present invention relates to a system for intracellular delivery of a cargo comprising at least one component A chosen from aliphatic linear or branched moieties with at least 4 carbon atoms and/or cyclic ring systems comprising 2-4 rings which may contain several hetero atoms chosen from N, S, O and P, wherein component(s) A is (are) attached to a cell penetrating peptide B and/or a non-peptide analogue thereof. It also relates to methods of using the system in diagnosis of diseases, as research tool and as a targeting system, a composition comprising the system and especially a pharmaceutical composition a material covered with the system and a material having the delivery systems into the material. Finally it relates to novel peptides."}, {"Patent No": "US20140140929A1", "Patent Link": "http://www.lens.org/lens/patent/US20140140929A1", "Patent Type": "Granted Patent", "Publication Date": "2014-5-22", "Family Info": "Notavailable", "Patent Title": "CHEMICALLY MODIFIED CELL-PENETRATING PEPTIDES FOR IMPROVED DELIVERY OF GENE MODULATING COMPOUNDS", "Abstract": "The present invention relates to a system for intracellular delivery of a cargo comprising at least one component A chosen from aliphatic linear or branched moieties with at least 4 carbon atoms and/or cyclic ring systems comprising 2-4 rings which may contain several hetero atoms chosen from N, S, O and P, wherein component(s) A is (are) attached to a cell penetrating peptide B and/or a non-peptide analogue thereof. It also relates to methods of using the system in diagnosis of diseases, as research tool and as a targeting system, a composition comprising the system and especially a pharmaceutical composition a material covered with the system and a material having the delivery systems into the material. Finally it relates to novel peptides."}], "Sequence Information": {"SPADE ID": "SPADE_N_06909", "Peptide Name": "M918", "Source": "Protein derived", "Family": "", "Gene": "Not found", "Sequence": "MVTVLFRRLRIRRACGPPRVRV", "Sequence Length": 22, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "Fluorescein", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C116H207N43O24S2", "Mass": 2652.29, "PI": 12.0, "Net Charge": 7, "Hydrophobicity": 0.1, "Half Life": "Mammalian:30 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "A novel cell-penetrating peptide, M918, for efficient delivery of proteins and peptide nucleic acids.", "Pubmed ID": "17622242", "Reference": "Mol Ther. 2007 Oct;15(10)1820-6.", "Author": "El-Andaloussi S, Johansson HJ, Holm T, Langel U.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=17622242"}], "Frequent Amino Acids": "RVL", "Absent Amino Acids": "DEHKNOQSUWY", "Basic Residues": 7, "Acidic Residues": 0, "Hydrophobic Residues": 12, "Polar Residues": 14, "Positive Residues": 7, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_06912", "Similarity": 0.7272727272727273, "Sequence": "MVRRFLVTLRIRRACGPPRVRV"}, {"SPADE_ID": "SPADE_N_07049", "Similarity": 0.7272727272727273, "Sequence": "MVRRFLVTLRIRRACGPPRVRVFVVHIPRLTGEWAAP"}, {"SPADE_ID": "SPADE_UN_15636", "Similarity": 0.6666666666666666, "Sequence": "RRIRIRPPRLPRPRPRPWFPPRFPIPRIPGKR"}]}}}